| EPIGEX |
|
EPIGEX proposes innovating tools for the research and development of epigenetic diseases encompassing cancer, inflammation, and auto-immune diseases. The company portfolio includes molecular biology reagents for the screening of therapeutic compounds, a technology for the cartography of protein interaction impaired in epigenetic diseases and a set of new tumor biomarkers. Key words : Epigenetic tools Protein interaction Tumor biomarkers Creation of the company : 2011 Company details :
|